ELASMOGEN LIMITEDActive
Key figures
ELASMOGEN LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2023/24–2024/25
| 2023/24 | 2024/25 | |
|---|---|---|
| Profit for the year | -2,246,783 | -1,757,496 |
| Cash at bank and in hand | 3,987,800 | 2,306,879 |
| Total assets | — | — |
| Total liabilities | — | — |
| Net assets / total equity | 4,488,338 | 2,806,508 |
| Average number of employees | 18 | 17 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company continued to be that of research and development work.
As described in the company's latest filed accounts.
Summary: ELASMOGEN LIMITED
Company
ELASMOGEN LIMITED is a private limited company registered with Companies House under company number SC467513. It was incorporated on 15 Jan 2014. Its status is active. The registered office is in Foresterhill (AB25). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Jan 2025); the company files full accounts. Loss for the year was £1,757,496. Net assets were £2,806,508, down 37.5% on the previous year. Cash at bank and in hand was £2,306,879. The company had an average of 17 employees. Figures are available for 2 financial years (2023/24–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 29 Jan 2027.